Products of the ras gene family, termed p21', are GTP-binding proteins that have been implicated in signal transduction via receptors encoding tyrosine kinase domains. Recent findings have defined a superfamily of hemopoietin receptors that includes receptors for a number of interleukins and colony-stimulating factors. The intracellular
portions of these receptors show only restricted homologies, have no tyrosine kinase domain, and provide no clues to the mode ofsignal transduction. However, in most cases the factors stimulate tyrosine phosphorylation. We demonstrate here that ligand-induced activation of the interleukin (IL)-2, 1L-3, IL-5, and granulocyte-macrophage colony-stimulating factor receptors resulted in activation of p2l' in various hemopoietic cell lines. The only cytokine tested that binds to a hemopoietin receptor and that did not activate p2l1 was 1L4. Activation of p2l1 was also observed in response to Steel factor, which stimulates the endogenous tyrosine kinase activity of the c-kit receptor, as well as with phorbol esters, which activate protein kinase C. Experiments with protein kinase inhibitors implicated tyrosine kinase activity, but not protein kinase C activity, as the upstream signal in p2l' activation via these growth factor receptors. Attempts to demonstrate tyrosine phosphorylation of the p21m GTPase-activating protein (GAP) were negative, suggesting that phosphorylation of GAP may not be the major mechanism for regulation of p21' activity by tyrosine kinases.
Hemopoietic cells grow in response to a number of growth factors that are referred to as interleukins (IL) and colony stimulating factors (CSF), all of which share only limited structural similarity and sequence homologies (1) . The restricted cell targets of these factors have now been shown to result from their interaction with a superfamily of receptors known as the hemopoietin receptors (for review, see ref. 2 ). This receptor family shares a number of highly conserved structural features, including a WSXWS motif, four conserved cysteines, and fibronectin binding domains. Binding of many of the factors to their receptors has been shown to activate tyrosine phosphorylation of a number of substrates but, with the possible exception of IL-2 (3), the tyrosine kinase that is activated has not been identified.
A large proportion of human tumors have been shown to express activated versions of the ras family of genes, whose products are collectively referred to as p2ls (4) . p2l"S are GTP-binding proteins that have been shown, by both indirect and direct approaches, to be involved in events downstream of tyrosine kinases. The anti-p21' monoclonal antibody Y13-259, when microinjected into cells, has been shown to inhibit serum and growth factor-induced stimulation of mitogenesis, as well as transformation by tyrosine kinaseencoding oncogenes (5, 6) . Several recent studies (7) (8) (9) have shown that both nonreceptor and receptor tyrosine kinases are able to stimulate p21 activity, as measured by an increase in the amount ofp2l' having bound GTP compared to GDP. A similar increase in the ratio of GTP/GDP was observed in T cells after stimulation of the T-cell antigen receptor or in response to phorbol esters (10) .
We demonstrate here that IL-2, IL-3, IL-5, granulocytemacrophage CSF (GM-CSF) and Steel factor (SLF), but not IL-4, activate p21"s in hemopoietic cells. Phorbol esters had a small effect on p21' activity, but it was much less than that of cytokines acting on the same cells. Furthermore, experiments with inhibitors of protein tyrosine kinases and of serine/threonine kinases suggest that tyrosine kinase activity, but not protein kinase C (PKC) activity, is required for this stimulation. Initial attempts to characterize the potential site of action of the tyrosine kinases focused on GTPaseactivating protein (GAP) (11, 12) , but no increase in its phosphorylation was observed with any of the factors tested. Therefore, the primary effect of tyrosine kinase activity in stimulation of p21s activity by the hemopoietic growth factors may be via tyrosine phosphorylation of other proteins involved in the regulation of p211s activity.
MATERIALS AND METHODS Materials. The following materials were from the sources indicated: RPMI 1640 and other media (Terry Fox Media Preparation Service, Vancouver, BC); [32P]orthophosphate (ICN); alkaline phosphatase-conjugated goat anti-mouse IgG (Calbiochem); 5-bromo-4-chloro-3-indolylphosphate (BCIP) and nitroblue tetrazolium chloride (NBT) (GIBCO/BRL); nitrocellulose (Schleicher & Schuell); protein A-Sepharose 4B (Pharmacia); 4G10 anti-phosphotyrosine antibody (Upstate Biotechnology, Lake Placid, NY). Synthetic forms of murine IL-3, IL-4, GM-CSF, and SLF were synthesized with an Applied Biosystems instrument as described (13) . Recombinant IL-2 and IL-5 were produced in a B-cell hybridoma cell line, X63Ag8-653 (from F. Melchers, Basel, Switzerland), transfected with a bovine papilloma virus-based expression vector (14) . Each of the factors used was shown to be free of contaminating activity. The Y13-259 hybridoma (15) (PBS) , and immunoprecipitated using Y13-259 as described (10) . Briefly, protein A-Sepharose beads were incubated in PBS containing 1.0 mg of bovine serum albumin per ml and a 1:50 dilution of rabbit anti-rat IgG antiserum followed by incubation with 10 ,ug of Y13-259 antibody per ml; samples were immunoprecipitated with 15 dul of antibody-coated packed beads. Bound GTP and GDP were eluted as described (10) and separated on polyethyleneimine-cellulose TLC sheets developed in 1.0 M KH2PO4 (pH 3.4) (19) . After autoradiography, the ratio of GTP/GDP was determined by a laser scanning densitometer (Molecular Dynamics). The response of the densitometer was shown to be linear over the range of radioactivity present in the GDP and GTP spots (10-250 cpm).
GAP Phosphorylation. GAP was immunoprecipitated from extracts of cells treated as indicated, essentially as described (20) . The GAP immunoprecipitates were analyzed by immunoblotting using 4G10 anti-phosphotyrosine antibody. Nitrocellulose blots were incubated overnight in blocking buffer containing 20 mM Tris*HCl (pH 7.5), 0.15 M NaCI, and 5% bovine serum albumin, 1% ovalbumin, and 0.05% sodium azide. Incubations with anti-phosphotyrosine antibody were in buffer containing 1% bovine serum albumin plus 0.5 jig of 4G10 per ml for 2 hr. Blots were washed and incubated in alkaline phosphatase-conjugated secondary antibody (1:2000 dilution of stock) for 1 hr. Color development was in 10 mM Tris-HCl, pH 9.5/100 mM NaCI/5 mM MgCl2 plus BCIP and NBT, as suggested by the manufacturer. As a positive control for tyrosine phosphorylation ofGAP, Rat-1 cells transformed with the PrA strain of wild-type v-src (21) were tested in the same assay. RESULTS IL-3 Rapidly Stimulates Increased GTP Association with p21m. The IL-3-dependent cell line R6X was treated for various times with a saturating concentration of synthetic IL-3. As indicated in Fig. 1 , there was an increase in the amount of GTP associated with p211s within 1 min and this reached a maximum level by 10 min. After 20 min of IL-3 treatment, the ratio of GTP/GDP had decreased. This result was seen consistently in several experiments, with the maximal effect observed between 5 and 10 min of treatment.
When R6X cells were analyzed for IL-3-induced tyrosine phosphorylation, very similar kinetics of phosphorylation were observed, reaching a maximal level by 10 short-term proliferation assays to IL-4. Each of the factors, with the exception of IL-4, was able to stimulate p21s (Fig.  2) . Table 1 summarizes these and other results using various cells and treatments. FDC-2 cells were found to respond to IL-2 as well as to IL-3. Similar to the results in MC-9, IL-4 did not have an effect on p211s in either FDC-2 or R6X. In all three cases, the cells are kept alive, but with only modest proliferation in the presence of . Phorbol esters were also tested in R6X and FDC-P1 cells and were found to increase the GTP/GDP ratio, although their effect was consistently less than that of the cytokines. Phorbol esters were also unable to stimulate growth of these cells. ++ ++
++
Chemically synthesized IL-3, IL-4, GM-CSF, and SLF were used; sources of IL-2 and IL-5 were supernatants of transfected cells. In each case, parallel experiments demonstrated that the same preparations of cytokines stimulated tyrosine phosphorylation of a characteristic pattern of substrates. Cytokines were added at concentrations and times known to stimulate maximum tyrosine phosphorylation. For SLF, the time was 2 min and for all others it was 10 min. PMA (10 nM) was added for 20 min and PDBU (100 nM) was added for 20 min. Results are presented in terms of the increase in p21ras-associated GTP as a percentage of total bound guanine nucleotides (0%o, no GTP bound; 100%o, no GDP bound). -, Treatments that resulted in an increase of <5%; +, increase of 5-10%o; + +, increase of 10-20o; + + +, increase of 20-30%; + + + +, increase of >30%. In most experiments, control cells had <5% GTP (and often <1%) associated with the immunoprecipitated p21rs. Each experiment was repeated at least twice, and in most cases at least three times, with similar results.
Inhibition of Tyrosine Kinase, but not PKC Activity, Blocked p2l' Activation. We used a series of tyrosine kinase and PKC inhibitors to evaluate their effects in inhibiting p2lraS activation. The first result suggesting the involvement of tyrosine kinase activity was obtained by using staurosporine (22) , an inhibitor of numerous protein kinases, and a structurally related inhibitor, no. 3, originally reported by Davis et al. (23) to be a more specific inhibitor of PKC. As shown in Fig. 3 , staurosporine was a potent inhibitor of IL-3 induced p2lras activation, while the PKC inhibitor no. 3 had almost no effect. The effectiveness of the inhibitors on PKC was confirmed by their inhibition of PKC activity in extracts of cells pretreated with inhibitors, as well as by their ability to inhibit phorbol ester-induced p21's activation (results not shown). Therefore, the IL-3-induced activation of p21's did not appear to be dependent on PKC activity. We have also observed that staurosporine, at concentrations equal to or lower than those used here, was a very potent inhibitor of tyrosine kinase activity stimulated by IL-3, whereas the PKC inhibitor no. 3 had no effect on tyrosine phosphorylation (results not shown). The latter observations led us to test a number of other tyrosine kinase inhibitors.
Two tyrosine kinase inhibitors, ST271 and ST638 (24), inhibited IL-3-induced increases in tyrosine phosphorylation while two other inhibitors, coded as nos. 25 and 47 by Gazit et al. (25) , were found to be much less effective (results not shown). As shown in Fig. 4 , ST271 and ST638 were very effective at blocking IL-3-stimulated p2l"S activation. The two inhibitors, nos. 25 and 47, were unable to block IL-3-stimulated p21aS activation, correlating with their inability to block IL-3-induced tyrosine phosphorylation (results not shown). Similar experiments showed that ST271 and ST638 also blocked SLF-induced tyrosine phosphorylation and another tyrosine kinase inhibitor, genistein, was an even more potent inhibitor (data not shown). As shown in Fig. 4 , genistein was a potent inhibitor of SLF-stimulated p2l'S 3 (23) for 2 min followed by IL-3 for 10 min. These results are from a representative experiment that was repeated three times. Similar results were also obtained when cells were preincubated with the inhibitors for up to 30 min. activation. ST271 and ST638 were also found to inhibit the SLF-induced effect when tested in one experiment. The tyrosine kinase inhibitors had no effect on the basal level of GTP bound to p21s when they were added alone to the cells (data not shown).
Tyrosine Phosphorylation of GAP Is Not Detected in Response to the Various Cytokines. Previous studies have suggested a role for tyrosine phosphorylation of GAP in the regulation of p21's. We tested this in our system by immunoprecipitation of GAP from cytokine-treated cells (Fig. 5) . MC-9 cells were treated with either IL-4, IL-5, GM-CSF, or SLF (Fig. 5A ), but in no case was there any detectable phosphorylation of GAP. Fig. 5B shows that stimulation of R6X cells with IL-3, followed by immunoprecipitation of GAP, also did not reveal any tyrosine-phosphorylated bands at the position expected for GAP. The same was true even when 4 times as many cells were used. As a positive control, it was shown that tyrosine-phosphorylated GAP, as well as p190 and p62, could be detected in an immunoprecipitate from only 1.0 x 106 v-src-transformed Rat-1 cells, as has been reported (26) . In addition, we demonstrated by blotting with anti-GAP antibodies that GAP had been immunoprecipitated in all cases (results not shown).
In no case was there any increase in the phosphorylation of p190 after stimulation with the cytokines. On the other hand, there was increased phosphorylation of a coimmunoprecipitated polypeptide at the position expected for p62 and this was found in all cases. The major bands below p62 represent the heavy chain of rabbit IgG that was detected due to the cross-reactivity of alkaline phosphatase-coupled goat anti-mouse IgG.
DISCUSSION
The activation of p211S in response to a number of growth factors, nonreceptor tyrosine kinases, and other cell stimuli has been demonstrated in several recent studies by assaying the increase in bound GTP associated with immunoprecipitated p21ls (7-10, 27, 28) . The results presented here show that a number of cytokines-IL-2, IL-3, IL-5, and GM-CSF-that bind to hemopoietin receptors were able to activate p211S. Another cytokine, SLF (29) , which acts on similar cell types but is the ligand for a tyrosine kinaseencoding receptor, c-kit, had a similar effect. Since plateletderived growth factor (PDGF) has also been shown to activate p21s (7, 8) , the latter result was not surprising, as the c-kit receptor protein is related to the PDGF receptor (30) . It was intriguing that only one of the cytokines tested, IL-4, gave a negative result. During the course of our study, Satoh et al. (28) reported that some of the same cytokines we had used-IL-2, IL-3, and GM-CSF-were able to activate p21ls, but IL-4 was not, even in a cell line growing in IL-4. Their study provided no characterization of the potential mechanisms involved in the activation. In our study, the IL-4-responsive cells showed only a limited proliferative response to the factor. Our attempts to obtain IL-4-dependent cells were unsuccessful, resulting only in factorindependent cells, so we have not been able to verify that IL-4 is unable to activate p21ls in an IL-4-dependent cell line.
One of the key aspects of p21ls activation that remains unresolved is the mechanism by which protein kinases are involved in its regulation. With the recent suggestion that PKC activity may be important in this process (10), we attempted to dissect the phosphorylation events that are necessary for p2lraS activation in hemopoietic cells. The kinetics of p211 activation correlated well with the stimulation of tyrosine phosphorylation by both IL-3 (V.D., I. Clark-Lewis, B. Federsppiel, J. S. Wieler, and J.W.S., unpublished observations) and SLF (M.J.W. and J.W.S., unpublished observations). We tested the effects of various inhibitors of protein kinases on IL-3-stimulated activation of p2iras. The inhibition of tyrosine phosphorylation by several tyrosine kinase inhibitors correlated with their ability to inhibit p21ls activation while a PKC inhibitor had no effect. We observed that phorbol 12-myristate 13-acetate (PMA) and phorbol 12,13-dibutyrate (PDBU) did activate p211s in the factor-dependent cell lines R6X and FDC-P1, similar to the results of Downward et al. (10) with T cells. However, the degree of activation was much smaller and the time required for activation was much longer than that found in response to cytokines. These results suggest that activation of PKC is not involved in the initial activation of p211 after stimulation via hemopoietin receptors, but activation of tyrosine phosphorylation is necessary.
Since both receptor and nonreceptor tyrosine kinases are able to stimulate the tyrosine phosphorylation of GAP (27, 28, 31, 32) , one might have assumed that GAP was a primary target of tyrosine kinases that influence p211 activity. However, GAP that is associated with p190 has been shown to have reduced activity, but this GAP is primarily serine phosphorylated (32) . If tyrosine phosphorylation of GAP or GAP-associated proteins were able to inhibit its GTPaseactivating activity, then the rate of GTP conversion to GDP would be decreased, and GDP-GTP exchange would result in increased p21' activity. As has been demonstrated in our study, although all of the factors we have tested are able to stimulate tyrosine phosphorylation of numerous substrates, the phosphorylation of GAP could not be detected. Likewise, Rottapel et al. (33) were unable to see GAP phosphorylation in response to SLF. Therefore, if tyrosine phosphorylation is directly affecting p21ras activity, as suggested by the rapid time course of activation and the effect of tyrosine kinase inhibitors, then there must be tyrosine-phosphorylated proteins other than GAP that are involved. Alternatively, GAP could be regulated by serine or threonine phosphorylation, as has been reported (10), but such an effect would not have been detected in our assays. It is interesting that of the two polypeptides, p190 and p62, that associate with GAP (26, 32) , p190 was tyrosine phosphorylated to the same extent in all samples, but there was increased tyrosine phosphorylation of p62 in factor-treated compared to control cells. The other interesting aspect of these results is that IL-4 was as effective as the other factors in stimulating tyrosine phosphorylation of p62, so its increased tyrosine phosphorylation is not sufficient for p21ls activation. Other potential targets of tyrosine phosphorylation include the recently described nucleotide exchange-promoting protein (34, 35) and the neurofibromatosis gene product (36, 37) . Whereas the latter has activity similar to GAP, which can only cause inactivation of p2ls, a nucleotide exchange protein may provide a target for positive regulation of p2l'S activity.
While activation of p2l's is common to a number of signal transduction pathways, its role in cell regulation is still poorly understood. The negative results with IL-4 in an IL-4-grown cell line (28) cause it to stand out as the only cytokine that does not stimulate p21's activity in hemopoietic cells. IL-4 stimulates tyrosine phosphorylation (refs. 38 and 39; V.D., unpublished observations), but very few cell types grow in response to IL-4, so it will be important to determine how those that do might have bypassed the need for p21's activation. The activation of p2l's by phorbol esters and via the T-cell receptor (10) also demonstrate that this effect is not seen exclusively as a consequence of, or in conjunction with, growth of cells. In the case of p21' activation by PKC, there is a possibility that this activation is not a primary event in response to growth factors, but it is a secondary phenomenon that may be involved in prolonging an initial activation event. While in many cases growth factors that interact with tyrosine kinase-encoding receptors can activate p21'S, one exception is the study by Burgering et al. (40) with insulin, PDGF, and epidermal growth factor, which yielded results opposite those of Satoh et al. (8, 9) using similar cell types.
The activation of p211s appears to be a point of convergence for signaling via IL-2, -3, and -5, and GM-CSF and SLF. In another study, we have demonstrated that IL-3, IL-5, GM-CSF and SLF, but not IL-4, promote tyrosine phosphorylation and activation of members of the microtubule-associated protein (MAP) kinase family of serine/ threonine protein kinases (M.J.W., V.D., J. S. Sanghera, S. L. Pelech, and J.W.S., unpublished observations). Future work needs to concentrate on the relationship between these two distinct points in the signal transduction pathways downstream of hemopoietic growth factor receptors, especially the tyrosine phosphorylation events that may be critical for each.
In summary, stimulation of p2l's is observed in response to various hemopoietic growth factors that act via either hemopoietin receptors or tyrosine kinase-encoding receptors in several hemopoietic cell types. The activation of p2l'S appears to require tyrosine phosphorylation, but not PKC activity, based on studies with protein kinase inhibitors. In our system, we cannot detect tyrosine phosphorylation of GAP, suggesting that other targets of tyrosine phosphorylation are involved in the activation of p21's.
